Christopher Barys

Christopher Barys

Directeur/Membre du Conseil chez UROLOGIX, INC.
59 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Christopher R.
Barys
is currently Chief Executive Officer & Non-Executive Director at Radiaction Ltd. since 2023, Independent Director at Urologix, Inc. since 2010, and Non-Executive Director at Compumedics Ltd. starting in 2025.
Former roles include President, Chief Executive Officer & Director at On Target Laboratories LLC from 2019 to 2023; Director-Global Market Development at Cordis Corp.
in 2005; Vice President-Sales & Marketing at Edwards Lifesciences Corp.
from 2005 to 2007; Chief Operating Officer at FlowCardia, Inc. from 2007 to 2010; and positions as Director at CloSys Corp., Principal at Johnson & Johnson and Boston Scientific Corp., Vice President & General Manager at I-Flow Corp., General Manager at Kimberly-Clark Health Care, Inc., Chief Operating Officer at Sonablate Corp., and VP & General Manager-Interventional Lung Solutions at Covidien Unlimited Co. Education includes undergraduate studies at Northern Illinois University.

Postes actifs de Christopher Barys

SociétésPosteDébut
UROLOGIX, INC. Directeur/Membre du Conseil 06/08/2010
COMPUMEDICS LIMITED Directeur/Membre du Conseil 22/09/2025
Directeur Général 01/08/2023

Anciens postes connus de Christopher Barys

SociétésPosteFin
Directeur Général 01/07/2023
Corporate Officer/Principal 01/02/2014
Directeur des opérations 01/06/2010
EDWARDS LIFESCIENCES CORPORATION Sales & Marketing 01/11/2007
Corporate Officer/Principal -
Voir l'expérience en détail de Christopher Barys

Formation de Christopher Barys

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

34

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

  1. Bourse
  2. Insiders
  3. Christopher Barys
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇